Could you expand on what you think MNTA will "discover" that will prompt Amphastar (and MNTA, to be sure) to settle out of court?
Here's my WAG,
Amphastar has to have a process for accurately characterizing their molecule. If they use a process that infringes on Momenta's patent(s), Amphastar will have to settle. It doesn't matter that Amphastar may have come up with an accurate process independently, it's a matter of patent protection.
aj